Market Overview

Benzinga's Top Initiations

Benzinga's Top Initiations
Related LJPC
The Most Notable Insider Buys And Sells Of Last Week
La Jolla Pharma Could Nearly Triple, Cowen Says
Related DRII
Benzinga's Top Downgrades
Watch These 7 Huge Call Purchases In Friday Trade

Analysts at Jefferies initiated coverage on La Jolla Pharma (NASDAQ: LJPC) with a Buy rating. The target price for La Jolla Pharma is set to $25. La Jolla Pharma's shares closed at $9.40 on Friday.

Imperial Capital initiated coverage on shares of Diamond Resorts (NYSE: DRII) with a Outperform rating. The target price for Diamond Resorts is set to $34. Diamond Resorts' shares closed at $24.95 on Friday.

Latest Ratings for LJPC

Jun 2016SunTrust Robinson HumphreyInitiates Coverage onBuy
Feb 2016Cowen & CompanyInitiates Coverage onOutperform
Apr 2015OppenheimerInitiates Coverage onOutperform

View More Analyst Ratings for LJPC
View the Latest Analyst Ratings

Posted-In: Top InitiationsInitiation Analyst Ratings


Related Articles (LJPC + DRII)

View Comments and Join the Discussion!